Inhibition of vascular smooth muscle cell proliferation by a novel fibroblast growth factor receptor antagonist

Photodynamic Therapy

1988 • 4,275 citations

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

1991 • 2,437 citations

Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal Angioplasty

1987 • 1,870 citations

Requirement of Heparan Sulfate for bFGF-Mediated Fibroblast Growth and Myoblast Differentiation

1991 • 1,507 citations

The Fgf Family of Growth Factors and Oncogenes

1992 • 1,164 citations

Crystal Structure of a Ternary FGF-FGFR-Heparin Complex Reveals a Dual Role for Heparin in FGFR Binding and Dimerization

2000 • 1,146 citations

A Hierarchical Network of Interreceptor Interactions Determines Signal Transduction by Neu Differentiation Factor/Neuregulin and Epidermal Growth Factor

1996 • 1,021 citations

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

1992 • 749 citations

Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor.

1991 • 722 citations

Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty.

1992 • 681 citations

Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.

1988 • 662 citations

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells.

1992 • 634 citations

Structural Basis for FGF Receptor Dimerization and Activation

1999 • 597 citations

Role of basic fibroblast growth factor in vascular lesion formation.

1991 • 521 citations

An Essential Heparin-Binding Domain in the Fibroblast Growth Factor Receptor Kinase

1993 • 520 citations

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.

1996 • 486 citations

Cancer Detection and Therapy. Affinity of Neoplastic, Embryonic, and Traumatized Tissues for Porphyrins and Metalloporphyrins.

1948 • 358 citations

Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.

1994 • 254 citations

Structural interactions of fibroblast growth factor receptor with its ligands

2000 • 231 citations

Angiogenic growth factors

1990 • 192 citations

Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. An en face study.

1993 • 174 citations

Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group.

1986 • 162 citations

Specificity for Fibroblast Growth Factors Determined by Heparan Sulfate in a Binary Complex with the Receptor Kinase

1999 • 148 citations

Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury.

1988 • 145 citations

Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasis.

2000 • 123 citations

Identification of Fibroblast Growth Factor 9 (FGF9) as a High Affinity, Heparin Dependent Ligand for FGF Receptors 3 and 2 but not for FGF Receptors 1 and 4

1995 • 110 citations

Properly Oriented Heparin−Decasaccharide-Induced Dimers Are the Biologically Active Form of Basic Fibroblast Growth Factor^,

1997 • 95 citations

Remodeling of the coronary artery after vascular injury

1997 • 85 citations

Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice

1986 • 80 citations

Diminished Heparin Binding of a Basic Fibroblast Growth Factor Mutant Is Associated with Reduced Receptor Binding, Mitogenesis, Plasminogen Activator Induction, and in vitro Angiogenesis

1994 • 69 citations

Inhibition of Collagen Synthesis, Smooth Muscle Cell Proliferation, and Injury-Induced Intimal Hyperplasia by Halofuginone

1997 • 67 citations

Multiple growth factors are released from mechanically injured vascular smooth muscle cells

1995 • 62 citations

Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: Implications in the treatment of restenosis after angioplasty

1994 • 51 citations

Inhcer of β-Interferon

1997 • 37 citations

Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2

1999 • 32 citations

Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.

1997 • 25 citations

Inhibitory effects of prostacyclin analogue, TFC-132, on aortic neointimal thickening in vivo and smooth muscle cell proliferation in vitro

1994 • 22 citations

Inhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran.

1996 • 20 citations